Table 4 One-year and five-year survival among breast cancer patients with available stage information (n=7702) in Denmark for three diagnostic periods
From: Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
Charlson score | |||
|---|---|---|---|
0 | 1–2 | 3+ | |
Breast cancer 1995–1997 | 2225 | 281 | 29 |
Stage | |||
Local | 1077 (48%) | 125 (44%) | 14 (48%) |
Regional | 962 (39%) | 88 (31%) | 6 (21%) |
Distant | 154 (7%) | 23 (8%) | 4 (14%) |
Unstaged | 132 (6%) | 45 (16%) | 5 (17%) |
1-year | |||
% Survival | 94% (93–95%) | 81% (76–86%) | 72% (52–85%) |
Crude MR | 1 (reference) | 3.45 (2.50–4.75) | 5.45 (2.67–11.14) |
MR adjusted for age and stage | 1 (reference) | 2.67 (1.94–3.72) | 3.33 (1.62–6.87) |
5-year | |||
% Survival | 73% (71–75%) | 48% (42–53%) | 45% (27–62%) |
Crude MR | 1 (reference) | 2.44 (2.04–2.93) | 2.92 (1.78–4.79) |
MR adjusted for age and stage | 1 (reference) | 1.92 (1.59–2.32) | 2.58 (1.56–4.25) |
Breast cancer 1998–2000 | 2399 | 301 | 42 |
Stage | |||
Local | 1149 (48%) | 130 (43%) | 25 (60%) |
Regional | 998 (42%) | 105 (34%) | 9 (21%) |
Distant | 138 (6%) | 27 (9%) | 1 (2%) |
Unstaged | 114 (5%) | 43 (14%) | 7 (17%) |
1-year | |||
% Survival | 94% (93–95%) | 83% (78–86%) | 81% (66–90%) |
Crude MR | 1 (reference) | 3.22 (2.35–4.42) | 3.61 (1.77–7.36) |
MR adjusted for age and stage | 1 (reference) | 2.14 (1.54–2.96) | 4.40 (2.11–9.14) |
5-year | |||
% Survival | 75% (74–77%) | 54% (48–60%) | 40% (25–54%) |
Crude MR | 1 (reference) | 2.27 (1.88–2.73) | 3.44 (2.30–5.13) |
MR adjusted for age and stage | 1 (reference) | 1.63 (1.35–1.98) | 3.78 (2.51–5.69) |
Breast cancer 2001–2004 | 2566 | 357 | 52 |
Stage | |||
Local | 1133 (44%) | 148 (41%) | 19 (37%) |
Regional | 1170 (46%) | 133 (37%) | 24 (46%) |
Distant | 114 (4%) | 23 (6%) | 3 (6%) |
Unstaged | 149 (6%) | 53 (15%) | 6 (12%) |
1-year | |||
% Survival | 95% (94–96%) | 87% (83–90%) | 71% (57–81%) |
Crude MR | 1 (reference) | 2.80 (2.01–3.89) | 6.43 (3.77–10.97) |
MR adjusted for age and stage | 1 (reference) | 1.91 (1.36–2.69) | 4.45 (2.58–7.66) |
